Thymosin Alpha-1 Frequently Asked Questions

Thymosin Alpha-1 is a 28-amino acid peptide naturally produced by the thymus gland. It was first isolated and characterised by Dr. Allan Goldstein in the 1970s. Thymosin Alpha-1 is a key regulator of immune cell maturation and function, particularly T-cell development. Peptides Pharma Thymosin Alpha-1 is formulated at >99% purity in a lyophilized vial.

Research indicates Thymosin Alpha-1 modulates the immune system through multiple mechanisms including stimulating T-cell maturation and differentiation, enhancing dendritic cell function, promoting natural killer cell activity, and modulating cytokine production. It acts on Toll-like receptors (TLR2 and TLR9) and influences both innate and adaptive immunity. These findings are from extensive published clinical and preclinical research.

Thymosin Alpha-1 is studied in research related to immune modulation, viral infections (including hepatitis B and C), vaccine adjuvancy, immunodeficiency, cancer immunology, sepsis, and age-related immune decline (immunosenescence). Its broad immunomodulatory profile makes it one of the most researched immune peptides globally.

Peptides Pharma Thymosin Alpha-1 is manufactured to >99% purity in GMP-certified, ISO 7 cleanroom facilities. Each batch is independently verified by HPLC and mass spectrometry testing. Certificates of Analysis confirming identity, purity, and sterility are available for all batches.

Lyophilized Thymosin Alpha-1 should be stored at -20°C for long-term storage or at 2-8°C for short-term use. Protect from light and moisture. After reconstitution, store at 2-8°C and use within 28 days for optimal peptide stability and activity.

Reconstitute Thymosin Alpha-1 by adding bacteriostatic water slowly down the inside wall of the vial. Allow the lyophilized powder to dissolve gently without vigorous agitation. The reconstitution volume determines the final concentration for your research dosing requirements.

Reconstituted Thymosin Alpha-1 stored at 2-8°C with bacteriostatic water is generally stable for up to 28 days. Maintain aseptic technique when accessing the vial to prevent microbial contamination and preserve the peptide's bioactivity.

Yes. Peptides Pharma Thymosin Alpha-1 is supplied exclusively for laboratory and research purposes. While Thymosin Alpha-1 has been approved as a medicine in some countries, Peptides Pharma's formulation is sold strictly as a research compound and is not intended for therapeutic use in the UK.

Thymosin Alpha-1 is one of several peptides naturally produced by the thymus gland, which is the primary organ responsible for T-cell maturation and immune system education. The thymus involutes (shrinks) with age, reducing natural Thymosin Alpha-1 production. This age-related decline is studied in the context of immunosenescence and age-related immune dysfunction.

Thymosin Alpha-1 is sometimes studied alongside other immune and anti-aging peptides such as TB-500 (which shares a thymic origin as Thymosin Beta-4) and BPC-157. Its immunomodulatory mechanism complements peptides acting through tissue repair or antioxidant pathways. Researchers should design combination protocols based on published peer-reviewed literature.